BlackRock (TMCI holder) files amended 13G showing 959,320 Treace Medical shares

BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 959,320 shares in Treace Medical Concepts, Inc., which represents 1.5% of the outstanding common stock. This filing indicates that BlackRock holds sole voting and dispositive power over these shares. While various underlying persons may have rights to dividends or sale proceeds, no single person possesses an interest exceeding five percent of Treace's outstanding common shares through these holdings.